loading controls Search Results


94
Bioss rabbit gapdh
A subset of novel k-FATs exhibits yeast toxicity and IcsB-like fatty acid acyltransferase activity. ( A ) Map of the pRS313 Gal1p2 centromeric plasmid used for the galactose-inducible expression of IcsB and its homologs. ( B )The expression of IcsB and seven of its homologs in the presence of galactose inhibits yeast growth compared to the empty vector (EV) control. The glucose plate indicates that there is no growth inhibition in the absence of expression and that similar amounts of each strain were plated. Four dilutions were plated (non-diluted, 1/10, 1/100, and 1/1,000). The graph represents the quantification of growth on three independent replicates of the 1/1,000 dilution. The error bars represent the standard deviation of the mean. A Student’s t-test with unpaired data and a 95% CI was performed (*, P < 0.05; **, P < 0.1, ***, P < 0.01). ( C ) Protein acylation in the membrane protein fraction of yeast expressing IcsB and its homologs according to the in-gel fluorescence acyltransferase assay (upper panels). -Alk IcsB is the IcsB sample prior to the addition of Alk-16. -Alk IcsB, Alk-16 EV, and Alk-16 IcsB were loaded on both gels to serve as controls. This acylation assay was performed using the strains from B that were induced with galactose for six hours in the presence of Alk-16 for the final 4 h. The total protein in these samples were assessed using the TGX stain (bottom panels). ( D ) The expression of IcsB and of its homologs was assessed by immunoblotting with an antibody binding to their 3× FLAG tag and with the <t>GAPDH</t> as a loading control.
Rabbit Gapdh, supplied by Bioss, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit gapdh/product/Bioss
Average 94 stars, based on 1 article reviews
rabbit gapdh - by Bioz Stars, 2026-05
94/100 stars
  Buy from Supplier

99
Danaher Inc anti gapdh antibodies
A subset of novel k-FATs exhibits yeast toxicity and IcsB-like fatty acid acyltransferase activity. ( A ) Map of the pRS313 Gal1p2 centromeric plasmid used for the galactose-inducible expression of IcsB and its homologs. ( B )The expression of IcsB and seven of its homologs in the presence of galactose inhibits yeast growth compared to the empty vector (EV) control. The glucose plate indicates that there is no growth inhibition in the absence of expression and that similar amounts of each strain were plated. Four dilutions were plated (non-diluted, 1/10, 1/100, and 1/1,000). The graph represents the quantification of growth on three independent replicates of the 1/1,000 dilution. The error bars represent the standard deviation of the mean. A Student’s t-test with unpaired data and a 95% CI was performed (*, P < 0.05; **, P < 0.1, ***, P < 0.01). ( C ) Protein acylation in the membrane protein fraction of yeast expressing IcsB and its homologs according to the in-gel fluorescence acyltransferase assay (upper panels). -Alk IcsB is the IcsB sample prior to the addition of Alk-16. -Alk IcsB, Alk-16 EV, and Alk-16 IcsB were loaded on both gels to serve as controls. This acylation assay was performed using the strains from B that were induced with galactose for six hours in the presence of Alk-16 for the final 4 h. The total protein in these samples were assessed using the TGX stain (bottom panels). ( D ) The expression of IcsB and of its homologs was assessed by immunoblotting with an antibody binding to their 3× FLAG tag and with the <t>GAPDH</t> as a loading control.
Anti Gapdh Antibodies, supplied by Danaher Inc, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti gapdh antibodies/product/Danaher Inc
Average 99 stars, based on 1 article reviews
anti gapdh antibodies - by Bioz Stars, 2026-05
99/100 stars
  Buy from Supplier

99
Danaher Inc anti hsp90
A subset of novel k-FATs exhibits yeast toxicity and IcsB-like fatty acid acyltransferase activity. ( A ) Map of the pRS313 Gal1p2 centromeric plasmid used for the galactose-inducible expression of IcsB and its homologs. ( B )The expression of IcsB and seven of its homologs in the presence of galactose inhibits yeast growth compared to the empty vector (EV) control. The glucose plate indicates that there is no growth inhibition in the absence of expression and that similar amounts of each strain were plated. Four dilutions were plated (non-diluted, 1/10, 1/100, and 1/1,000). The graph represents the quantification of growth on three independent replicates of the 1/1,000 dilution. The error bars represent the standard deviation of the mean. A Student’s t-test with unpaired data and a 95% CI was performed (*, P < 0.05; **, P < 0.1, ***, P < 0.01). ( C ) Protein acylation in the membrane protein fraction of yeast expressing IcsB and its homologs according to the in-gel fluorescence acyltransferase assay (upper panels). -Alk IcsB is the IcsB sample prior to the addition of Alk-16. -Alk IcsB, Alk-16 EV, and Alk-16 IcsB were loaded on both gels to serve as controls. This acylation assay was performed using the strains from B that were induced with galactose for six hours in the presence of Alk-16 for the final 4 h. The total protein in these samples were assessed using the TGX stain (bottom panels). ( D ) The expression of IcsB and of its homologs was assessed by immunoblotting with an antibody binding to their 3× FLAG tag and with the <t>GAPDH</t> as a loading control.
Anti Hsp90, supplied by Danaher Inc, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti hsp90/product/Danaher Inc
Average 99 stars, based on 1 article reviews
anti hsp90 - by Bioz Stars, 2026-05
99/100 stars
  Buy from Supplier

96
Boster Bio anti β actin
A subset of novel k-FATs exhibits yeast toxicity and IcsB-like fatty acid acyltransferase activity. ( A ) Map of the pRS313 Gal1p2 centromeric plasmid used for the galactose-inducible expression of IcsB and its homologs. ( B )The expression of IcsB and seven of its homologs in the presence of galactose inhibits yeast growth compared to the empty vector (EV) control. The glucose plate indicates that there is no growth inhibition in the absence of expression and that similar amounts of each strain were plated. Four dilutions were plated (non-diluted, 1/10, 1/100, and 1/1,000). The graph represents the quantification of growth on three independent replicates of the 1/1,000 dilution. The error bars represent the standard deviation of the mean. A Student’s t-test with unpaired data and a 95% CI was performed (*, P < 0.05; **, P < 0.1, ***, P < 0.01). ( C ) Protein acylation in the membrane protein fraction of yeast expressing IcsB and its homologs according to the in-gel fluorescence acyltransferase assay (upper panels). -Alk IcsB is the IcsB sample prior to the addition of Alk-16. -Alk IcsB, Alk-16 EV, and Alk-16 IcsB were loaded on both gels to serve as controls. This acylation assay was performed using the strains from B that were induced with galactose for six hours in the presence of Alk-16 for the final 4 h. The total protein in these samples were assessed using the TGX stain (bottom panels). ( D ) The expression of IcsB and of its homologs was assessed by immunoblotting with an antibody binding to their 3× FLAG tag and with the <t>GAPDH</t> as a loading control.
Anti β Actin, supplied by Boster Bio, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti β actin/product/Boster Bio
Average 96 stars, based on 1 article reviews
anti β actin - by Bioz Stars, 2026-05
96/100 stars
  Buy from Supplier

93
Rockland Immunochemicals anti gapdh antibody
A subset of novel k-FATs exhibits yeast toxicity and IcsB-like fatty acid acyltransferase activity. ( A ) Map of the pRS313 Gal1p2 centromeric plasmid used for the galactose-inducible expression of IcsB and its homologs. ( B )The expression of IcsB and seven of its homologs in the presence of galactose inhibits yeast growth compared to the empty vector (EV) control. The glucose plate indicates that there is no growth inhibition in the absence of expression and that similar amounts of each strain were plated. Four dilutions were plated (non-diluted, 1/10, 1/100, and 1/1,000). The graph represents the quantification of growth on three independent replicates of the 1/1,000 dilution. The error bars represent the standard deviation of the mean. A Student’s t-test with unpaired data and a 95% CI was performed (*, P < 0.05; **, P < 0.1, ***, P < 0.01). ( C ) Protein acylation in the membrane protein fraction of yeast expressing IcsB and its homologs according to the in-gel fluorescence acyltransferase assay (upper panels). -Alk IcsB is the IcsB sample prior to the addition of Alk-16. -Alk IcsB, Alk-16 EV, and Alk-16 IcsB were loaded on both gels to serve as controls. This acylation assay was performed using the strains from B that were induced with galactose for six hours in the presence of Alk-16 for the final 4 h. The total protein in these samples were assessed using the TGX stain (bottom panels). ( D ) The expression of IcsB and of its homologs was assessed by immunoblotting with an antibody binding to their 3× FLAG tag and with the <t>GAPDH</t> as a loading control.
Anti Gapdh Antibody, supplied by Rockland Immunochemicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti gapdh antibody/product/Rockland Immunochemicals
Average 93 stars, based on 1 article reviews
anti gapdh antibody - by Bioz Stars, 2026-05
93/100 stars
  Buy from Supplier

93
Rockland Immunochemicals rabbit anti β actin antibody
A subset of novel k-FATs exhibits yeast toxicity and IcsB-like fatty acid acyltransferase activity. ( A ) Map of the pRS313 Gal1p2 centromeric plasmid used for the galactose-inducible expression of IcsB and its homologs. ( B )The expression of IcsB and seven of its homologs in the presence of galactose inhibits yeast growth compared to the empty vector (EV) control. The glucose plate indicates that there is no growth inhibition in the absence of expression and that similar amounts of each strain were plated. Four dilutions were plated (non-diluted, 1/10, 1/100, and 1/1,000). The graph represents the quantification of growth on three independent replicates of the 1/1,000 dilution. The error bars represent the standard deviation of the mean. A Student’s t-test with unpaired data and a 95% CI was performed (*, P < 0.05; **, P < 0.1, ***, P < 0.01). ( C ) Protein acylation in the membrane protein fraction of yeast expressing IcsB and its homologs according to the in-gel fluorescence acyltransferase assay (upper panels). -Alk IcsB is the IcsB sample prior to the addition of Alk-16. -Alk IcsB, Alk-16 EV, and Alk-16 IcsB were loaded on both gels to serve as controls. This acylation assay was performed using the strains from B that were induced with galactose for six hours in the presence of Alk-16 for the final 4 h. The total protein in these samples were assessed using the TGX stain (bottom panels). ( D ) The expression of IcsB and of its homologs was assessed by immunoblotting with an antibody binding to their 3× FLAG tag and with the <t>GAPDH</t> as a loading control.
Rabbit Anti β Actin Antibody, supplied by Rockland Immunochemicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit anti β actin antibody/product/Rockland Immunochemicals
Average 93 stars, based on 1 article reviews
rabbit anti β actin antibody - by Bioz Stars, 2026-05
93/100 stars
  Buy from Supplier

99
Danaher Inc gapdh
A subset of novel k-FATs exhibits yeast toxicity and IcsB-like fatty acid acyltransferase activity. ( A ) Map of the pRS313 Gal1p2 centromeric plasmid used for the galactose-inducible expression of IcsB and its homologs. ( B )The expression of IcsB and seven of its homologs in the presence of galactose inhibits yeast growth compared to the empty vector (EV) control. The glucose plate indicates that there is no growth inhibition in the absence of expression and that similar amounts of each strain were plated. Four dilutions were plated (non-diluted, 1/10, 1/100, and 1/1,000). The graph represents the quantification of growth on three independent replicates of the 1/1,000 dilution. The error bars represent the standard deviation of the mean. A Student’s t-test with unpaired data and a 95% CI was performed (*, P < 0.05; **, P < 0.1, ***, P < 0.01). ( C ) Protein acylation in the membrane protein fraction of yeast expressing IcsB and its homologs according to the in-gel fluorescence acyltransferase assay (upper panels). -Alk IcsB is the IcsB sample prior to the addition of Alk-16. -Alk IcsB, Alk-16 EV, and Alk-16 IcsB were loaded on both gels to serve as controls. This acylation assay was performed using the strains from B that were induced with galactose for six hours in the presence of Alk-16 for the final 4 h. The total protein in these samples were assessed using the TGX stain (bottom panels). ( D ) The expression of IcsB and of its homologs was assessed by immunoblotting with an antibody binding to their 3× FLAG tag and with the <t>GAPDH</t> as a loading control.
Gapdh, supplied by Danaher Inc, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/gapdh/product/Danaher Inc
Average 99 stars, based on 1 article reviews
gapdh - by Bioz Stars, 2026-05
99/100 stars
  Buy from Supplier

98
AvesLabs act
A subset of novel k-FATs exhibits yeast toxicity and IcsB-like fatty acid acyltransferase activity. ( A ) Map of the pRS313 Gal1p2 centromeric plasmid used for the galactose-inducible expression of IcsB and its homologs. ( B )The expression of IcsB and seven of its homologs in the presence of galactose inhibits yeast growth compared to the empty vector (EV) control. The glucose plate indicates that there is no growth inhibition in the absence of expression and that similar amounts of each strain were plated. Four dilutions were plated (non-diluted, 1/10, 1/100, and 1/1,000). The graph represents the quantification of growth on three independent replicates of the 1/1,000 dilution. The error bars represent the standard deviation of the mean. A Student’s t-test with unpaired data and a 95% CI was performed (*, P < 0.05; **, P < 0.1, ***, P < 0.01). ( C ) Protein acylation in the membrane protein fraction of yeast expressing IcsB and its homologs according to the in-gel fluorescence acyltransferase assay (upper panels). -Alk IcsB is the IcsB sample prior to the addition of Alk-16. -Alk IcsB, Alk-16 EV, and Alk-16 IcsB were loaded on both gels to serve as controls. This acylation assay was performed using the strains from B that were induced with galactose for six hours in the presence of Alk-16 for the final 4 h. The total protein in these samples were assessed using the TGX stain (bottom panels). ( D ) The expression of IcsB and of its homologs was assessed by immunoblotting with an antibody binding to their 3× FLAG tag and with the <t>GAPDH</t> as a loading control.
Act, supplied by AvesLabs, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/act/product/AvesLabs
Average 98 stars, based on 1 article reviews
act - by Bioz Stars, 2026-05
98/100 stars
  Buy from Supplier

93
Cell Signaling Technology Inc loading controls gapdh
Expression levels <t>of</t> <t>PGC‐1α</t> and associated genes in dystrophic muscles. A) Western blotting of PGC‐1α1 and PGC‐1α4 protein levels ( n = 3 mice). B) Quantitative analysis of the western blot bands normalized to <t>GAPDH.</t> C) Relative mRNA expression levels of total Pgc‐1α (Pgc‐1α1,2,3, and 4), Pgc‐1α1, and Pgc‐1α4. D–K) Relative mRNA levels of genes associated with PGC‐1α in various aspects including muscle hypertrophy (D), myogenic induction (E), mitochondrial activity (F), angiogenesis (G), neuromuscular junction (NMJ) (H), myofiber type (I), metabolism (J), and inflammation (K). All analyses were performed using plantar flexor muscles. Data are presented as mean ± SEM ( n = 6 mice), and Welch's t ‐test was used ( *** p < 0.001, ** p < 0.01, and * p < 0.05).
Loading Controls Gapdh, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/loading controls gapdh/product/Cell Signaling Technology Inc
Average 93 stars, based on 1 article reviews
loading controls gapdh - by Bioz Stars, 2026-05
93/100 stars
  Buy from Supplier

91
Rockland Immunochemicals vdac rabbit pab
Expression levels <t>of</t> <t>PGC‐1α</t> and associated genes in dystrophic muscles. A) Western blotting of PGC‐1α1 and PGC‐1α4 protein levels ( n = 3 mice). B) Quantitative analysis of the western blot bands normalized to <t>GAPDH.</t> C) Relative mRNA expression levels of total Pgc‐1α (Pgc‐1α1,2,3, and 4), Pgc‐1α1, and Pgc‐1α4. D–K) Relative mRNA levels of genes associated with PGC‐1α in various aspects including muscle hypertrophy (D), myogenic induction (E), mitochondrial activity (F), angiogenesis (G), neuromuscular junction (NMJ) (H), myofiber type (I), metabolism (J), and inflammation (K). All analyses were performed using plantar flexor muscles. Data are presented as mean ± SEM ( n = 6 mice), and Welch's t ‐test was used ( *** p < 0.001, ** p < 0.01, and * p < 0.05).
Vdac Rabbit Pab, supplied by Rockland Immunochemicals, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/vdac rabbit pab/product/Rockland Immunochemicals
Average 91 stars, based on 1 article reviews
vdac rabbit pab - by Bioz Stars, 2026-05
91/100 stars
  Buy from Supplier

93
Rockland Immunochemicals rabbit anti alpha tubulin
Expression levels <t>of</t> <t>PGC‐1α</t> and associated genes in dystrophic muscles. A) Western blotting of PGC‐1α1 and PGC‐1α4 protein levels ( n = 3 mice). B) Quantitative analysis of the western blot bands normalized to <t>GAPDH.</t> C) Relative mRNA expression levels of total Pgc‐1α (Pgc‐1α1,2,3, and 4), Pgc‐1α1, and Pgc‐1α4. D–K) Relative mRNA levels of genes associated with PGC‐1α in various aspects including muscle hypertrophy (D), myogenic induction (E), mitochondrial activity (F), angiogenesis (G), neuromuscular junction (NMJ) (H), myofiber type (I), metabolism (J), and inflammation (K). All analyses were performed using plantar flexor muscles. Data are presented as mean ± SEM ( n = 6 mice), and Welch's t ‐test was used ( *** p < 0.001, ** p < 0.01, and * p < 0.05).
Rabbit Anti Alpha Tubulin, supplied by Rockland Immunochemicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit anti alpha tubulin/product/Rockland Immunochemicals
Average 93 stars, based on 1 article reviews
rabbit anti alpha tubulin - by Bioz Stars, 2026-05
93/100 stars
  Buy from Supplier

93
Novus Biologicals quikchip kit
Expression levels <t>of</t> <t>PGC‐1α</t> and associated genes in dystrophic muscles. A) Western blotting of PGC‐1α1 and PGC‐1α4 protein levels ( n = 3 mice). B) Quantitative analysis of the western blot bands normalized to <t>GAPDH.</t> C) Relative mRNA expression levels of total Pgc‐1α (Pgc‐1α1,2,3, and 4), Pgc‐1α1, and Pgc‐1α4. D–K) Relative mRNA levels of genes associated with PGC‐1α in various aspects including muscle hypertrophy (D), myogenic induction (E), mitochondrial activity (F), angiogenesis (G), neuromuscular junction (NMJ) (H), myofiber type (I), metabolism (J), and inflammation (K). All analyses were performed using plantar flexor muscles. Data are presented as mean ± SEM ( n = 6 mice), and Welch's t ‐test was used ( *** p < 0.001, ** p < 0.01, and * p < 0.05).
Quikchip Kit, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/quikchip kit/product/Novus Biologicals
Average 93 stars, based on 1 article reviews
quikchip kit - by Bioz Stars, 2026-05
93/100 stars
  Buy from Supplier

Image Search Results


A subset of novel k-FATs exhibits yeast toxicity and IcsB-like fatty acid acyltransferase activity. ( A ) Map of the pRS313 Gal1p2 centromeric plasmid used for the galactose-inducible expression of IcsB and its homologs. ( B )The expression of IcsB and seven of its homologs in the presence of galactose inhibits yeast growth compared to the empty vector (EV) control. The glucose plate indicates that there is no growth inhibition in the absence of expression and that similar amounts of each strain were plated. Four dilutions were plated (non-diluted, 1/10, 1/100, and 1/1,000). The graph represents the quantification of growth on three independent replicates of the 1/1,000 dilution. The error bars represent the standard deviation of the mean. A Student’s t-test with unpaired data and a 95% CI was performed (*, P < 0.05; **, P < 0.1, ***, P < 0.01). ( C ) Protein acylation in the membrane protein fraction of yeast expressing IcsB and its homologs according to the in-gel fluorescence acyltransferase assay (upper panels). -Alk IcsB is the IcsB sample prior to the addition of Alk-16. -Alk IcsB, Alk-16 EV, and Alk-16 IcsB were loaded on both gels to serve as controls. This acylation assay was performed using the strains from B that were induced with galactose for six hours in the presence of Alk-16 for the final 4 h. The total protein in these samples were assessed using the TGX stain (bottom panels). ( D ) The expression of IcsB and of its homologs was assessed by immunoblotting with an antibody binding to their 3× FLAG tag and with the GAPDH as a loading control.

Journal: mBio

Article Title: A bacterial family of fatty acid acyltransferases related to the Shigella effector IcsB

doi: 10.1128/mbio.03890-25

Figure Lengend Snippet: A subset of novel k-FATs exhibits yeast toxicity and IcsB-like fatty acid acyltransferase activity. ( A ) Map of the pRS313 Gal1p2 centromeric plasmid used for the galactose-inducible expression of IcsB and its homologs. ( B )The expression of IcsB and seven of its homologs in the presence of galactose inhibits yeast growth compared to the empty vector (EV) control. The glucose plate indicates that there is no growth inhibition in the absence of expression and that similar amounts of each strain were plated. Four dilutions were plated (non-diluted, 1/10, 1/100, and 1/1,000). The graph represents the quantification of growth on three independent replicates of the 1/1,000 dilution. The error bars represent the standard deviation of the mean. A Student’s t-test with unpaired data and a 95% CI was performed (*, P < 0.05; **, P < 0.1, ***, P < 0.01). ( C ) Protein acylation in the membrane protein fraction of yeast expressing IcsB and its homologs according to the in-gel fluorescence acyltransferase assay (upper panels). -Alk IcsB is the IcsB sample prior to the addition of Alk-16. -Alk IcsB, Alk-16 EV, and Alk-16 IcsB were loaded on both gels to serve as controls. This acylation assay was performed using the strains from B that were induced with galactose for six hours in the presence of Alk-16 for the final 4 h. The total protein in these samples were assessed using the TGX stain (bottom panels). ( D ) The expression of IcsB and of its homologs was assessed by immunoblotting with an antibody binding to their 3× FLAG tag and with the GAPDH as a loading control.

Article Snippet: Primary antibodies used were mouse FLAG-tag (Sigma-Aldrich, F3165), mouse Myc-tag (Genescript, A00704), and rabbit GAPDH (Bioss antibodies, BS-8789R) diluted 1/5,000, 1/1,000, and 1/10,000, respectively.

Techniques: Activity Assay, Plasmid Preparation, Expressing, Control, Inhibition, Standard Deviation, Membrane, Fluorescence, Staining, Western Blot, Binding Assay, FLAG-tag

Mutations in the catalytic site of k-FATs abolish their enzymatic activity. ( A ) Yeast growth inhibition tests of catalytic residues mutants H145A (left), D195A (center), and C306A (right) compared to their WT counterpart in IcsB and in toxic homologs. The graph represents the quantification of growth on three independent replicates with the dilution of yeast cultures 1/1,000. The error bars represent the standard deviation from the mean. A Student’s t -test with unpaired data and a 95% CI was performed (*, P < 0.05; **, P < 0.1, ***, P < 0.01). ( B ) In-gel protein acylation of C306A mutants compared to their WT counterparts (upper panels). The total protein in these samples were assessed using the TGX stain (bottom panels). ( C ) The expression of IcsB and toxic homolog C306A mutants was compared to their WT counterparts by immunoblotting with an antibody binding to their 3×FLAG tag and with the GAPDH as a loading control.

Journal: mBio

Article Title: A bacterial family of fatty acid acyltransferases related to the Shigella effector IcsB

doi: 10.1128/mbio.03890-25

Figure Lengend Snippet: Mutations in the catalytic site of k-FATs abolish their enzymatic activity. ( A ) Yeast growth inhibition tests of catalytic residues mutants H145A (left), D195A (center), and C306A (right) compared to their WT counterpart in IcsB and in toxic homologs. The graph represents the quantification of growth on three independent replicates with the dilution of yeast cultures 1/1,000. The error bars represent the standard deviation from the mean. A Student’s t -test with unpaired data and a 95% CI was performed (*, P < 0.05; **, P < 0.1, ***, P < 0.01). ( B ) In-gel protein acylation of C306A mutants compared to their WT counterparts (upper panels). The total protein in these samples were assessed using the TGX stain (bottom panels). ( C ) The expression of IcsB and toxic homolog C306A mutants was compared to their WT counterparts by immunoblotting with an antibody binding to their 3×FLAG tag and with the GAPDH as a loading control.

Article Snippet: Primary antibodies used were mouse FLAG-tag (Sigma-Aldrich, F3165), mouse Myc-tag (Genescript, A00704), and rabbit GAPDH (Bioss antibodies, BS-8789R) diluted 1/5,000, 1/1,000, and 1/10,000, respectively.

Techniques: Activity Assay, Inhibition, Standard Deviation, Staining, Expressing, Western Blot, Binding Assay, Control

Expression levels of PGC‐1α and associated genes in dystrophic muscles. A) Western blotting of PGC‐1α1 and PGC‐1α4 protein levels ( n = 3 mice). B) Quantitative analysis of the western blot bands normalized to GAPDH. C) Relative mRNA expression levels of total Pgc‐1α (Pgc‐1α1,2,3, and 4), Pgc‐1α1, and Pgc‐1α4. D–K) Relative mRNA levels of genes associated with PGC‐1α in various aspects including muscle hypertrophy (D), myogenic induction (E), mitochondrial activity (F), angiogenesis (G), neuromuscular junction (NMJ) (H), myofiber type (I), metabolism (J), and inflammation (K). All analyses were performed using plantar flexor muscles. Data are presented as mean ± SEM ( n = 6 mice), and Welch's t ‐test was used ( *** p < 0.001, ** p < 0.01, and * p < 0.05).

Journal: Advanced Science

Article Title: Polyplex Nanomicelle‐Mediated Pgc‐1α4 mRNA Delivery Via Hydrodynamic Limb Vein Injection Enhances Damage Resistance in Duchenne Muscular Dystrophy Mice

doi: 10.1002/advs.202409065

Figure Lengend Snippet: Expression levels of PGC‐1α and associated genes in dystrophic muscles. A) Western blotting of PGC‐1α1 and PGC‐1α4 protein levels ( n = 3 mice). B) Quantitative analysis of the western blot bands normalized to GAPDH. C) Relative mRNA expression levels of total Pgc‐1α (Pgc‐1α1,2,3, and 4), Pgc‐1α1, and Pgc‐1α4. D–K) Relative mRNA levels of genes associated with PGC‐1α in various aspects including muscle hypertrophy (D), myogenic induction (E), mitochondrial activity (F), angiogenesis (G), neuromuscular junction (NMJ) (H), myofiber type (I), metabolism (J), and inflammation (K). All analyses were performed using plantar flexor muscles. Data are presented as mean ± SEM ( n = 6 mice), and Welch's t ‐test was used ( *** p < 0.001, ** p < 0.01, and * p < 0.05).

Article Snippet: Membranes were blocked with 5% non‐fat dry milk and incubated with primary antibodies against PGC‐1α (sc‐518025, Santa Cruz; ST1202, Calbiochem) and loading controls GAPDH (D16H11, Cell Signaling Technology) and α‐tubulin (T6199, Sigma–Aldrich).

Techniques: Expressing, Muscles, Western Blot, Activity Assay

General upregulation of dysregulated genes after nanomicelle‐delivered Pgc‐1α4 mRNA treatment. A,B) Western blotting images of PGC‐1α4 protein expression on day 2 (A) and day 7 (B). C) Quantification of western blotting bands normalized to GAPDH (for day 2, n = 5 for the LNP + α4 group, n = 6 for all other groups; for day 7, n = 4 for the LNP + α4 group, n = 5 for the micelle + Fluc group, and n = 6 for the micelle + α4 group). D–L) Relative mRNA levels of genes associated with PGC‐1α on day 2 and day 7. All analyses were performed using plantar flexor muscle samples. Data are presented as mean ± SEM ( n = 6 mice), and one‐way ANOVA followed by Tukey's post hoc test was used ( *** p < 0.001, ** p < 0.01, and * p < 0.05).

Journal: Advanced Science

Article Title: Polyplex Nanomicelle‐Mediated Pgc‐1α4 mRNA Delivery Via Hydrodynamic Limb Vein Injection Enhances Damage Resistance in Duchenne Muscular Dystrophy Mice

doi: 10.1002/advs.202409065

Figure Lengend Snippet: General upregulation of dysregulated genes after nanomicelle‐delivered Pgc‐1α4 mRNA treatment. A,B) Western blotting images of PGC‐1α4 protein expression on day 2 (A) and day 7 (B). C) Quantification of western blotting bands normalized to GAPDH (for day 2, n = 5 for the LNP + α4 group, n = 6 for all other groups; for day 7, n = 4 for the LNP + α4 group, n = 5 for the micelle + Fluc group, and n = 6 for the micelle + α4 group). D–L) Relative mRNA levels of genes associated with PGC‐1α on day 2 and day 7. All analyses were performed using plantar flexor muscle samples. Data are presented as mean ± SEM ( n = 6 mice), and one‐way ANOVA followed by Tukey's post hoc test was used ( *** p < 0.001, ** p < 0.01, and * p < 0.05).

Article Snippet: Membranes were blocked with 5% non‐fat dry milk and incubated with primary antibodies against PGC‐1α (sc‐518025, Santa Cruz; ST1202, Calbiochem) and loading controls GAPDH (D16H11, Cell Signaling Technology) and α‐tubulin (T6199, Sigma–Aldrich).

Techniques: Western Blot, Expressing